Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer

Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer

BackgroundDespite immune checkpoint inhibitors(ICIs) significantly improve clinical outcomes in patients with advanced non-small cell lung cancer (aNSCLC), disease progression is inevitable. A diverse patient-reported Quality-of-life(QoL) scales were used to predict outcomes for aNSCLC patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Juanyan Shen, Junliang Ma, Shaolin Chen, Su-Han Jin, Junzhu Xu, Qisha Li, Chi Zhang, Xiaojing Tian, Xiaofei Chen, Fangya Tan, Markus Hecht, Benjamin Frey, Udo S. Gaipl, Hu Ma, Jian-Guo Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
quality of life
consensus clustering
atezolizumab
NSCLC
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1600265/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1600265/full

Similar Items